0001209191-15-019706.txt : 20150228
0001209191-15-019706.hdr.sgml : 20150227
20150227171944
ACCESSION NUMBER: 0001209191-15-019706
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150226
FILED AS OF DATE: 20150227
DATE AS OF CHANGE: 20150227
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 252025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-9911
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Furfine Eric Steven
CENTRAL INDEX KEY: 0001590220
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 15660620
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-02-26
0
0001485003
Eleven Biotherapeutics, Inc.
EBIO
0001590220
Furfine Eric Steven
C/O ELEVEN BIOTHERAPEUTICS, INC.,
215 FIRST STREET, SUITE 400
CAMBRIDGE
MA
02142
0
1
0
0
Chief Science Officer
Stock Option
10.39
2015-02-26
4
A
0
52500
0.00
A
2025-02-25
Common Stock
52500
217854
D
This option was granted on February 26, 2015 and vests over four years in equal quarterly installments, with the first installment vesting on March 31, 2015.
/s/ Eric Steven. Furfine
2015-02-26